What is the primary diagnostic test for achalasia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Primary Diagnostic Test for Achalasia

High-resolution esophageal manometry is the gold standard and required diagnostic test for achalasia, demonstrating the two cardinal features: absent esophageal peristalsis and failure of the lower esophageal sphincter to relax. 1, 2, 3

Diagnostic Algorithm

Step 1: Clinical Suspicion

  • Suspect achalasia when patients present with dysphagia to both solids and liquids simultaneously from disease onset—this pattern distinguishes achalasia from mechanical obstruction 1, 4
  • Additional red flags include postprandial regurgitation of undigested food, chest pain (especially in Type II and III), and pulmonary symptoms from nocturnal aspiration 1, 4

Step 2: Initial Evaluation

  • Upper endoscopy must be performed first to exclude mechanical obstruction (tumors, strictures) and other structural causes 2, 3
  • Look for retained saliva and puckering of the gastroesophageal junction as diagnostic clues 2
  • Barium esophagram provides complementary anatomic information, showing dilated esophagus with "bird beak" appearance and assessing for end-stage changes 5, 2

Step 3: Confirmatory Testing

  • High-resolution manometry (HRM) is mandatory to establish the diagnosis 1, 6, 7
  • HRM must demonstrate:
    • Absent or aperistaltic esophageal body contractions (94-100% of cases) 6
    • Incomplete lower esophageal sphincter relaxation with elevated integrated relaxation pressure (IRP) 1, 7
  • HRM also classifies the Chicago Classification subtype (I, II, or III), which directly determines treatment selection and prognosis 1, 8, 2

Critical Diagnostic Pitfalls

Early Disease

  • In early achalasia, the IRP may fall below the upper normal limit, potentially causing a false-negative manometry result 1, 4
  • Functional luminal imaging probe (FLIP) or timed barium esophagram may be needed when clinical suspicion remains high despite borderline manometry 1

Late/End-Stage Disease

  • In advanced Type I achalasia, both LES pressure and IRP can be paradoxically very low, mimicking absent contractility rather than achalasia 1, 4
  • Timed barium esophagram becomes essential in these cases to demonstrate impaired esophageal emptying and confirm the diagnosis 1, 5

EGJ Outflow Obstruction

  • This entity can mimic achalasia but may represent incomplete/early disease or a distinct pathology 1, 8
  • Before committing to permanent interventions, perform endoscopic ultrasound and CT imaging of the esophagogastric junction to exclude secondary causes (malignancy, infiltrative disease) 9, 1
  • Many cases resolve spontaneously; observation may be appropriate 9

Complementary Diagnostic Tools

  • Timed barium esophagram (TBE) quantitatively assesses esophageal emptying and is useful for diagnosis when manometry is equivocal and for monitoring treatment response 5, 3
  • Functional luminal imaging probe (FLIP) measures distensibility and supports achalasia diagnosis when manometry shows borderline findings 9

Why Manometry is Essential

High-resolution manometry with esophageal pressure topography is more sensitive than conventional water-perfused manometry and provides detailed pressure patterns that identify the three clinically relevant subtypes 7:

  • Type I (minimal pressurization): end-stage disease with variable treatment success 1, 8
  • Type II (pan-esophageal pressurization): best prognosis with 90-100% treatment success 1, 8
  • Type III (premature spastic contractions): poorest response to standard therapy (29-33% success), requires extended myotomy via POEM 9, 8

Without manometric confirmation and subtype classification, optimal treatment selection is impossible. 1, 8, 2

References

Guideline

Differentiating Dysphagia from Achalasia and Guideline‑Based Diagnostic Approach

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

ACG Clinical Guidelines: Diagnosis and Management of Achalasia.

The American journal of gastroenterology, 2020

Research

Achalasia: Diagnosis, Management and Surveillance.

Gastroenterology clinics of North America, 2021

Guideline

Clinical Manifestations of Achalasia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Esophageal achalasia--manometric patterns.

Romanian journal of internal medicine = Revue roumaine de medecine interne, 2009

Guideline

Achalasia Cardia Classification and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

In a 68-year-old obese man with diabetes mellitus and longstanding gastroesophageal reflux disease who now has worsening heartburn, frequent regurgitation, and postprandial chest pain despite a prior negative esophagogastroduodenoscopy, which study is required to confirm achalasia?
What complaints should be monitored in a patient with a history of achalasia?
What are the potential causes and management options for a middle-aged or older adult with a history of achalasia and previous Peroral Endoscopic Myotomy (POEM) surgery, who continues to experience occasional chest pain?
What are the possible causes of achalasia-like symptoms in a patient with a percutaneous endoscopic gastrostomy (PEG) tube?
In a 68-year-old man with obesity, diabetes mellitus, longstanding GERD, worsening heartburn despite proton pump inhibitor therapy, frequent regurgitation, and post‑prandial chest pain with a normal esophagogastroduodenoscopy, which diagnostic study is required to confirm achalasia?
What is a T1 low‑risk polyp‑contained colorectal cancer?
For an acute gout flare, should NSAIDs be used as first‑line therapy or is colchicine preferred, especially if the patient has renal impairment, peptic‑ulcer disease, uncontrolled hypertension, heart failure, or is on anticoagulants?
What is the most likely cause of hypotension in a patient taking trimetazidine, dapagliflozin, oxycodone 6.5 mg, duloxetine, and gabapentin MR 400 mg?
What are the typical symptoms and recommended treatment regimen for upper respiratory tract infections (URTIs) in otherwise healthy adults and children?
Can ramosetron be used in patients with hepatic impairment, and are dose adjustments required for mild, moderate, or severe liver disease?
What prophylaxis (antibiotic chemoprophylaxis and diphtheria toxoid vaccination) is recommended for individuals with close exposure to a confirmed case of diphtheria?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.